CN104356070A - Synthesis method of sodium glycididazole - Google Patents

Synthesis method of sodium glycididazole Download PDF

Info

Publication number
CN104356070A
CN104356070A CN201410737685.8A CN201410737685A CN104356070A CN 104356070 A CN104356070 A CN 104356070A CN 201410737685 A CN201410737685 A CN 201410737685A CN 104356070 A CN104356070 A CN 104356070A
Authority
CN
China
Prior art keywords
glycididazole
acid
sodium
stirring
adds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201410737685.8A
Other languages
Chinese (zh)
Inventor
冯柏年
宣坚钢
范文华
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
JIANGSU AIFAN BIOLOGICAL PHARMACEUTICAL Co Ltd
Original Assignee
JIANGSU AIFAN BIOLOGICAL PHARMACEUTICAL Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by JIANGSU AIFAN BIOLOGICAL PHARMACEUTICAL Co Ltd filed Critical JIANGSU AIFAN BIOLOGICAL PHARMACEUTICAL Co Ltd
Priority to CN201410737685.8A priority Critical patent/CN104356070A/en
Publication of CN104356070A publication Critical patent/CN104356070A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/91Nitro radicals
    • C07D233/92Nitro radicals attached in position 4 or 5
    • C07D233/94Nitro radicals attached in position 4 or 5 with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to other ring members

Abstract

The invention discloses a synthesis method of sodium glycididazole, belonging to the field of medical chemistry. The method comprises the following steps: carrying out esterification reaction on metronidazole and nitrilotriacetic acid by using concentrated sulfuric acid as a solvent and catalyst, and salifying with sodium bicarbonate. The preparation method disclosed by the invention has the adavantages of short steps, high yield and low cost, and is simple to operate, beneficial to environmental protection and suitable for industrial production.

Description

A kind of synthetic method of sodium glycididazole
Technical field
The present invention relates to a kind of synthetic method of sodium glycididazole, belong to medicinal chemistry arts.
Background technology
Cancer is a class disease higher with mortality ratio of falling ill in the world, the life of the serious threat mankind.Radiotherapy is one of Main Means for the treatment of malignant tumour at present, and Tumor cell hypoxia is the major reason causing radiotherapy failure, because noumenal tumour is central and connect the situation that ectocentral tumour cell all exists blood supply insufficiency, Cell hypoxia, and anoxic cell has resistance effect to low LET ray.Sodium glycididazole (CMNa) is that the anoxic cell of a unique high-efficiency low-toxicity formally applied clinically both at home and abroad at present has obvious radiosensitizing effect, and normal tissue has no significant effect.
The chemical combination synthetic method of sodium glycididazole mainly contains following several: (1) is under strict anhydrous condition, with nitrilotriacetic acid(NTA), acetic anhydride, metronidazole Reactive Synthesis Glycididazole in pyridine, the technique of Reactive Synthesis sodium glycididazole after mixing with sodium bicarbonate again, but the smell is awful for the pyridine used by reaction, harmful, and environmental pollution.(2) take nitrilotriacetic acid(NTA) as raw material, with acetic anhydride in N, N-dimethylformamide, obtain with sodium bicarbonate salify again after product purification, but the reagent used is difficult has pollution to environment, and overall yield of reaction is lower, only 21.2-28.9%.(3) take iminodiethanoic acid as starting raw material, react with Acetyl Chloride 98Min./anhydrous sodium acetate in DMF, the two azoles ester of imido is become again with metronidazole, then glycididazole acid is condensed into Mono Chloro Acetic Acid, finally become Glycididazole sodium salt trihydrate with 40% sodium hydroxide ethanolic soln, Acetyl Chloride 98Min. is used in this invention, and the smell is awful, and corrodibility is strong, and the Mono Chloro Acetic Acid used is for have infringement to health.
Summary of the invention
Technical problem to be solved by this invention is to overcome above-mentioned mentioned series of problems, should environmentally safe, and harmless to operator, source chemicals low price, improves reaction yield again.
The invention provides a kind of synthetic method of sodium glycididazole, its reaction scheme is as follows:
Described synthetic method be with metronidazole and nitrilotriacetic acid(NTA) for substrate, using the vitriol oil as catalysts and solvents, carry out esterification and obtain glycididazole acid, then obtain sodium glycididazole through salt-forming reaction.
In one embodiment of the invention, the preparation of glycididazole acid mainly comprises the following steps:
(1) three-necked flask in add the vitriol oil, and add nitrilotriacetic acid(NTA), under strong stirring, add metronidazole and holding temperature 0-15 DEG C in batches;
(2) finish, oil bath is heated, and to make in system temperature rise to 55-85 DEG C;
(3) stirring reaction 20-30h at 55-85 DEG C;
(4) stop stirring, while hot by reaction solution down in frozen water, stirring lower is 6-7 with mineral alkali adjust pH, controls interior temperature and is less than 10 DEG C;
(5) reaction solution is left standstill 12h at 0 DEG C, solid is separated out;
(6) filter, filter cake is washed; Vacuum drying obtains white crude solid.
In one embodiment of the invention, the consumption mol ratio of nitrilotriacetic acid(NTA) and metronidazole is 1:2.2.
In another embodiment of the invention, described mineral alkali is strong aqua, salt of wormwood, sodium carbonate, sodium bicarbonate, saleratus, sodium hydroxide or potassium hydroxide.
In another embodiment of the invention, described mineral alkali is strong aqua.
In another embodiment of the invention, the preparation of glycididazole acid also comprises further purification step: added to by crude product in organic solvent, and add hot breakdown backflow, filter, solid dries to obtain white solid.
Described making beating organic solvent is ethanol, methylene dichloride, methyl alcohol or tetrahydrofuran (THF), particular methanol.
In one embodiment of the invention, described salt-forming reaction is that glycididazole acid and sodium carbonate are obtained by reacting sodium glycididazole.
In one embodiment of the invention, described salt-forming reaction mainly comprises the following steps:
(1) water is added in reaction flask, be warming up to 40 ~ 60 DEG C, glycididazole acid is scattered in water, adds sodium bicarbonate solid in batches;
(2) in 40 ~ 60 DEG C of stirring and dissolving.Add gac insulation 0.5h, filter, filtrate is washed by ethyl acetate, and concentrated aqueous phase obtains off-white color to micro-yellow crystalline powder shape sodium glycididazole (containing 3 crystal water).Yield 82-87%.
The consumption mol ratio of described glycididazole acid and sodium bicarbonate is 1:0.85.
The inventive method environmentally safe, harmless to operator, source chemicals low price, and improve reaction yield.
Embodiment
The present invention is further illustrated by the following examples.Preparation method described in the embodiment of the present invention is only for illustration of the present invention, is not limitation of the present invention.
Embodiment 1
1, the preparation of glycididazole acid
(1) in the three-necked flask of 5000mL, add the 1200g vitriol oil, and add 401g (2.1mol) nitrilotriacetic acid(NTA), add 790g (4.62mol) metronidazole under strong stirring, holding temperature 0-15 DEG C in process in batches.
(2) finish, oil bath is heated, and makes temperature rise to 55 DEG C in system.
(3) stirring reaction 24h at 55 DEG C.
(4) stop stirring, while hot by reaction solution down in 5000mL frozen water, stirring lower is 6-7 with strong aqua adjust pH, controls interior temperature and is less than 10 DEG C.
(5) reaction solution is left standstill 12h at 0 DEG C, solid is separated out.
(6) filter, filter cake is washed.Vacuum drying obtains 300g white crude solid.
(7) added in 2000mL methyl alcohol by 300g crude product, add hot breakdown and reflux 1 hour, filter, solid dries to obtain 260g white solid, is glycididazole acid.The ratio of actual output and theoretical yield, i.e. yield are 26%.
2, the preparation-salt-forming reaction of sodium glycididazole
(1) 500mL water is added in reaction flask, be warming up to 40 DEG C, 100g (0.2mol) glycididazole acid is scattered in water, add and add 14.3g (0.17mol) sodium bicarbonate solid in batches.
(2) in 40 ~ 60 DEG C of stirring and dissolving.Add gac insulation 0.5h, filter, filtrate is washed by ethyl acetate, and concentrated aqueous phase obtains 90g off-white color to micro-yellow crystalline powder shape sodium glycididazole (containing 3 crystal water), yield 78%.
Embodiment 2
1, the preparation of glycididazole acid
(1) in the three-necked flask of 5000mL, add the 1200g vitriol oil, and add 401g (2.1mol) nitrilotriacetic acid(NTA), add 790g (4.62mol) metronidazole under strong stirring, holding temperature 0-15 DEG C in process in batches.
(2) finish, oil bath is heated, and makes temperature rise to 65 DEG C in system.
(3) stirring reaction 24h at 65 DEG C.
(4) stop stirring, while hot by reaction solution down in 5000mL frozen water, stirring lower is 6-7 with strong aqua adjust pH, controls interior temperature and is less than 10 DEG C.
(5) reaction solution is left standstill 12h at 0 DEG C, solid is separated out.
(6) filter, filter cake is washed.Vacuum drying obtains 450g white crude solid.
(7) added in 2000mL methyl alcohol by 450g crude product, add hot breakdown and reflux 1 hour, filter, solid dries to obtain 400g white solid, is the glycididazole acid of purity 95%, yield 38.5%.
2, the preparation-salt-forming reaction of sodium glycididazole
(1) 500mL water is added in reaction flask, be warming up to 40 DEG C, 100g (0.2mol) glycididazole acid is scattered in water, add and add 14.3g (0.17mol) sodium bicarbonate solid in batches.
(2) in 40 ~ 60 DEG C of stirring and dissolving.Add gac insulation 0.5h, filter, filtrate is washed by ethyl acetate, and concentrated aqueous phase obtains the sodium glycididazole 100g (containing 3 crystal water) of off-white color to micro-yellow crystalline powder shape purity 98.5%, yield 87%.Embodiment 3
1, the preparation of glycididazole acid
(1) in the three-necked flask of 5000mL, add the 1200g vitriol oil, and add 401g (2.1mol) nitrilotriacetic acid(NTA), add 790g (4.62mol) metronidazole under strong stirring, holding temperature 0-15 DEG C in process in batches.
(2) finish, oil bath is heated, and makes temperature rise to 85 DEG C in system.
(3) stirring reaction 24h at 85 DEG C.
(4) stop stirring, while hot by reaction solution down in 5000mL frozen water, stirring lower is 6-7 with strong aqua adjust pH, controls interior temperature and is less than 10 DEG C.
(5) reaction solution is left standstill 12h at 0 DEG C, solid is separated out.
(6) filter, filter cake is washed.Vacuum drying obtains 350g white crude solid.
(7) added in 2000mL methyl alcohol by 350g crude product, add hot breakdown and reflux 1 hour, filter, solid dries to obtain 300g white solid, is glycididazole acid.Yield: 29%.
2, the preparation-salt-forming reaction of sodium glycididazole
(1) 500mL water is added in reaction flask, be warming up to 40 DEG C, 100g (0.2mol) glycididazole acid is scattered in water, add and add 14.3g (0.17mol) sodium bicarbonate solid in batches.
(2) in 40 ~ 60 DEG C of stirring and dissolving.Add gac insulation 0.5h, filter, filtrate is washed by ethyl acetate, and concentrated aqueous phase obtains 93g off-white color to micro-yellow crystalline powder shape sodium glycididazole (containing 3 crystal water), yield: 81%.
Although the present invention with preferred embodiment openly as above; but it is also not used to limit the present invention, any person skilled in the art, without departing from the spirit and scope of the present invention; all can do various changes and modification, what therefore protection scope of the present invention should define with claims is as the criterion.

Claims (10)

1. a synthetic method for sodium glycididazole, is characterized in that, with metronidazole and nitrilotriacetic acid(NTA) for substrate, using the vitriol oil as catalysts and solvents, carries out esterification and obtains glycididazole acid, then obtain sodium glycididazole through salt-forming reaction.
2. method according to claim 1, it is characterized in that, the preparation of described glycididazole acid mainly comprises the following steps: (1) adds the vitriol oil in three-necked flask, and adds nitrilotriacetic acid(NTA), adds metronidazole and holding temperature 0-15 DEG C under strong stirring in batches; (2) finish, oil bath is heated, and to make in system temperature rise to 55-85 DEG C; (3) stirring reaction 20-30h at 55-85 DEG C; (4) stop stirring, while hot by reaction solution down in frozen water, stirring lower is 6-7 with mineral alkali adjust pH, controls interior temperature and is less than 10 DEG C; (5) reaction solution is left standstill 12h at 0 DEG C, solid is separated out; (6) filter, filter cake is washed, and dries to obtain Glycididazole acid crude.
3. method according to claim 2, is characterized in that, the mol ratio of nitrilotriacetic acid(NTA) and metronidazole is 1:2.2.
4. method according to claim 2, is characterized in that, described mineral alkali is strong aqua, salt of wormwood, sodium carbonate, sodium bicarbonate, saleratus, sodium hydroxide or potassium hydroxide.
5. the method according to claim 2 or 4, is characterized in that, described mineral alkali is strong aqua.
6. method according to claim 2, is characterized in that, also comprises and adds in organic solvent by crude product, and add hot breakdown backflow, filter, solid dries to obtain white solid.
7. method according to claim 6, is characterized in that, selected making beating organic solvent is ethanol, methylene dichloride, methyl alcohol or tetrahydrofuran (THF).
8. the method according to claim 6 or 7, is characterized in that, selected making beating organic solvent is methyl alcohol.
9. method according to claim 1, is characterized in that, described salt-forming reaction mainly comprises the following steps: water adds in reaction flask by (1), is warming up to 40 ~ 60 DEG C, is scattered in by glycididazole acid in water, adds and add sodium bicarbonate solid in batches; (2) in 40 ~ 60 DEG C of stirring and dissolving, add gac insulation 0.5h, filter, filtrate is washed by ethyl acetate, and concentrated aqueous phase obtains off-white color to micro-yellow crystalline powder shape sodium glycididazole.
10. a synthetic method for glycididazole acid, is characterized in that, with metronidazole and nitrilotriacetic acid(NTA) for substrate, using the vitriol oil as catalysts and solvents, carries out esterification and obtains glycididazole acid.
CN201410737685.8A 2014-12-05 2014-12-05 Synthesis method of sodium glycididazole Pending CN104356070A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410737685.8A CN104356070A (en) 2014-12-05 2014-12-05 Synthesis method of sodium glycididazole

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410737685.8A CN104356070A (en) 2014-12-05 2014-12-05 Synthesis method of sodium glycididazole

Publications (1)

Publication Number Publication Date
CN104356070A true CN104356070A (en) 2015-02-18

Family

ID=52523407

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410737685.8A Pending CN104356070A (en) 2014-12-05 2014-12-05 Synthesis method of sodium glycididazole

Country Status (1)

Country Link
CN (1) CN104356070A (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1046157A (en) * 1989-04-08 1990-10-17 中国人民解放军第二军医大学 A kind of synthetic method of cancer-eliminating medicine-metronizolamic acid
CN1270062A (en) * 1999-04-08 2000-10-18 广州山河药业股份有限公司 Glycobiazole metal salt as synergist for radiotherapy or chemicotherapy and its preparing process and application
CN1603312A (en) * 2003-09-29 2005-04-06 广州莱泰制药有限公司 Process for synthesis of sodium glycididazole
CN102190626A (en) * 2010-03-15 2011-09-21 南京莱因医药科技有限公司 Synthesis method of sodium glycididazole

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1046157A (en) * 1989-04-08 1990-10-17 中国人民解放军第二军医大学 A kind of synthetic method of cancer-eliminating medicine-metronizolamic acid
CN1270062A (en) * 1999-04-08 2000-10-18 广州山河药业股份有限公司 Glycobiazole metal salt as synergist for radiotherapy or chemicotherapy and its preparing process and application
CN1603312A (en) * 2003-09-29 2005-04-06 广州莱泰制药有限公司 Process for synthesis of sodium glycididazole
CN102190626A (en) * 2010-03-15 2011-09-21 南京莱因医药科技有限公司 Synthesis method of sodium glycididazole

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
吕亮: "《精细有机合成单元反应》", 30 June 2012, article "酯化反应", pages: 135-136 *
房鼎业等: "《化学工艺学 精编版》", 31 December 2012, article "酯化", pages: 354 *
胡昱等: "《有机化学实验》", 31 August 2012, article "酯化反应", pages: 101-102 *
赵宪瑞等: "含氮羧酸的羟乙基甲硝唑酯的合成", 《北京大学学报》, vol. 38, no. 2, 31 March 2002 (2002-03-31), pages 175 - 180 *

Similar Documents

Publication Publication Date Title
CN103910679B (en) The preparation method of the assorted Shandong of a kind of grace amine
CN103724261A (en) Novel industrial production method for hydroxychloroquine sulfate
CN102731605B (en) A kind of purification process of Abiraterone acetate
CN105566215A (en) Preparation method of Stivarga
CN102442972B (en) Industrial preparation method for pramipexole and its dihydrochloride monohydrate
CN102911164A (en) Method for preparing lapatinib key intermediate
CN102351790B (en) Method for synthesizing 7-bromo-6-chloro-4-quinazolinone
CN104086392A (en) Catalytic synthesis method for biphenylacetic acid
CN104370745B (en) The preparation method of rosin acid derivative
CN103012268B (en) Novel preparation method for ivabradine
CN103450005B (en) A kind of preparation method of clopidogrel and the alpha-brominated (2-Chlorophenyl)acetic acid of intermediate and α-thiophene ethamine base substituted acetic acid hydrochlorate
CN105330560A (en) Enzalutamide intermediate preparation method
CN102417486B (en) Method for synthesizing valsartan
CN103113294A (en) Synthesizing method of rebamipide
CN103588765A (en) Synthesis method for azilsartan medoxomil or salt thereof, intermediate of azilsartan medoxomil or salt thereof and synthesis method for intermediate
CN104356070A (en) Synthesis method of sodium glycididazole
CN103183629A (en) Process of effectively synthesizing important pharmaceutical and chemical intermediate 5-bromoindole
CN104072364A (en) Preparation method for diflunisal and catalyst thereof
CN103923003A (en) Preparation method of 4-bromomethylquinoline-2(H)-ketone
CN102690211B (en) The preparation method of tolvaptan intermediate
CN103058884B (en) Method for synthesizing 1-hydroxymethyl cyclopropyl acetonitrile
CN104529726A (en) Preparation method of hydroxyacetophenone
CN103980257B (en) The synthetic method of 8-nitro-2-tetrazole base-4-carbonyl chromene
CN105418507A (en) Preparation method for 1-(3-methyl-1-phenyl-1H-pyrazole-5-yl)piperazine
CN103910695B (en) A kind of synthetic method of Febuxostat

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20150218